Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 69Advanced Solid Tumor 58Solid Tumor 50Solid Tumors 42Mesothelioma 39Mesothelioma, Malignant 36Hematopoietic and Lymphatic System Neoplasm 24Solid Tumor, Adult 15Ovarian Neoplasms 13Malignant Solid Neoplasm 13Carcinoma, Non-Small-Cell Lung 13Melanoma 12Pancreatic Neoplasms 11Sarcoma 10Retinoblastoma 9Colorectal Neoplasms 9Stomach Neoplasms 8Lung Neoplasms 8Advanced Malignant Solid Neoplasm 8Solid Tumours 7Small Cell Lung Carcinoma 7Cholangiocarcinoma 7Carcinoma, Renal Cell 7Advanced or Metastatic Solid Tumors 7Kidney Neoplasms 6Carcinoma, Hepatocellular 6Advanced/Metastatic Solid Tumors 6Advanced Malignant Solid Tumor 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Other solid neoplasm × 90 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡